Europe
Royalty Increases Offer for Elan
Royalty Pharma increases offer for Elan. Royalty Pharma has increased its offer to purchase Elan Corp by 12%. The new bid is now worth US$6. 4 billion, even after the Irish drugmaker has been making moves seeking to prevent the takeover bid and boost revenues for the company.
KazAgro Raises US$1 Billion in Debt Issue
KazAgro raises half of its projected US$2 billion Eurobond issue programme. KazAgro, the state holding firm of Kazakhstan, has raised US$1 billion in its initial Eurobond issue.
Electranova Capital Supports Forsee Power
Electranova Capital invests in Forsee Power for development and growth purposes. In an announcement, Electranova disclosed its investment in Forsee Power Solutions.
Finnish Mobile DNA to be Auctioned Off
Banking circles are aswirl with talk of the auction sale for DNA mobile of Finland. A group of bankers are putting together a fund worth just under Eur1 billion or US$1.